Induction of vascular cell adhesion molecule-1 by low-density lipoprotein

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 185-194

  Lin, Jane H C ^a   Zhu, Yi ^b   Liao, Hai Ling ^b   Kobari, Yukage ^a   Groszek, Laura ^a   Stemerman, Michael B ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; endothelial cells; GATA; hypercholesterolemia; promoter activation; vascular adhesion molecule

Indexed keywords

LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; ELECTROPHORESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID METABOLISM; MONOCYTE; NORTHERN BLOTTING; PLAQUE FORMING CELL; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CELL ADHESION; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GATA2 TRANSCRIPTION FACTOR; HUMANS; LIPOPROTEINS, LDL; MONOCYTES; NF-KAPPA B; RISK FACTORS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030596089     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05951-5     Document Type: Article

References (58)

1. [1] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. [2] Grundy SM. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 1995;41:139-146.
3. [3] Luscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993;44:395-418.
4. [4] Pritchard KA, Jr., Groszek L, Smalley DM et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995;77:510-518.
5. [5] Holland JA, Pritchard KA, Rogers NJ, Stemerman MB. Perturbation of cultured human endothelial cells by atherogenic levels of low density lipoprotein. Am J Pathol 1988;132:474-478.
6. [6] Pritchard KA, Jr., Wong PY, Stemerman MB. Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products. Am J Pathol 1990;136:1383-1391.
7. [7] Holland JA, Pritchard KA, Rogers NJ, Stemerman MB. Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells. Am J Pathol 1992;140:551-558.
8. [8] Pritchard KA, Jr., Tota RR, Lin JH et al. Native low density lipoprotein. Endothelial cell recruitment of mononuclear cells. Arterioscler Thromb 1991;11:1175-1181.
9. [9] Hirai A, Kino T, Tokinaga K, Tahara K, Tamura Y, Yoshida S. Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation: a key role for free cholesterol content. J Clin Invest 1994;94:2215-2223.
10. [10] Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791.
11. [11] Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994;266:H2568-H2572.
12. [12] Lin JH, Villalon P, Martasek P, Abraham NG. Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney. Eur J Biochem 1990;192:577-582.
13. [13] Lin JH, Kobari Y, Zhu Y, Stemerman MB, Pritchard KA, Jr. Human umbilical vein endothelial cells express P450 2C8 mRNA: cloning of endothelial cell P450 epoxygenase. Endothelium 1996;4:219-229.
14. [14] Polte T, Newman W, Gopal TV. Full length vascular cell adhesion molecule 1 (VCAM-1). Nucleic Acids Res 1990;18:5901.
15. [15] Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
16. [16] Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992;176:1583-1593.
17. [17] Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. Wiley, New York, 1992;9.1.1-9.1.7.
18. [18] Avruch J, Zhang XF, Kyriakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 1994;19:279-283.
19. [19] Rosenthal N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol 1987; 152:704-720.
20. [20] Schreiber E, Matthias P. Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
21. [21] Ahmad M, Marui N, Alexander RW, Medford RM. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J Biol Chem 1995;270:8976-8983.
22. [22] Dent CL, Latchman DS. The DNA mobility shift assay. In: Latchman DS. (ed). Transcription Factors: A Practical Approach. IRL Press at Oxford University Press, New York, 1993;1-26.
23. [23] Smalley DM, Lin JH, Italiano ML, Kobari Y, Stemerman MB, Pritchard KA, Jr. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1. Arterioscler Thromb Vasc Biol 1996;16:585-590.
24. [24] Hauser IA, Johnson DR, Madri JA. Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion. J Immunol 1993;151:5172-5185.
25. [25] Faruqi R, de la Motte C. DiCorleto PE. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994;94:592-600.
26. [26] Pritchard KA, Jr., Holland JA, Rogers NJ et al. Low-density lipoprotein preparation by combined diafiltration and ultracentrifugation. Anal Biochem 1988;174:121-127.
27. [27] Miller YI, Shaklai N. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. Biochem Mol Biol Int 1994;34:1121-1129.
28. [28] Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:357-364.
29. [29] Moynagh PN, Williams DC, O'Neill LA. Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1: modulation by antioxidants. J Immunol 1994;153:2681-2690.
30. [30] Li H, Cybulsky MI, Gimbrone MA, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204.
31. [31] Marui N, Offermann MK, Swerlick R et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993;92:1866-1874.
32. [32] Sheppard AM, McQuillan JJ, Iademarco MF, Dean DC. Control of vascular cell adhesion molecule-1 gene promoter activity during neural differentiation. J Biol Chem 1995;270:3710-3719.
33. [33] Weber C, Erl W, Pietsch A et al. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994;14:1665-1673.
34. [34] Muller JM, Ziegler Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993; 187:233-256.
35. [35] Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspective based on Framingham study. Ann Int Med 1979;90:85-91.
36. [36] Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-1270.
37. [37] Iademarco MF, McQuillan JJ, Dean DC. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci USA 1993;90:3943-3947.
38. [38] McCarty JM, Yee EK, Deisher TA, Harlan JM, Kaushansky K. Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kappa b-independent mechanism. FEBS Lett 1995;372:194-198.
39. [39] Bender JR, Sadeghi MM, Watson C, Pfau S, Pardi R. Heterogeneous activation thresholds to cytokines in genetically distinct endothelial cells: evidence for diverse transcriptional responses. Proc Natl Acad Sci USA 1994;91:3994-3998.
40. [40] Stuhlmeier KM, Csizmadia V, Cheng Q, Winkler H, Bach FH. Selective inhibition of E-selectoin, ICAM-1, and VCAM in endothelial cells. Eur J Immunol 1994;24:2186-2190.
41. [41] Cobb RR, Felts KA, McKenzie TC, Parry GCN, Mackman NA. Benzothiophene-carboxamide is a potent inhibitor of IL-1 β induced VCAM-1 gene expression in human endothelial cells. FEBS Lett 1996;382:323-326.
42. [42] Zimmerman GA, Whatley RE, McIntyre TM, Benson DM, Prescott SM. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites. Methods Enzymol 1990;187:520-535.
43. [43] Malle E, Ibovnik A, Leis HJ, Kostner GM, Verhallen PFJ, Sattler W. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal of malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler Thromb Vasc Biol 1995;15:377-384.
44. [44] Watson AD, Navab M, Hama SY et al. Effect of platelet factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 1995;95:774-782.
45. [45] Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993;92:471-478.
46. [46] Haller H, Schaper D, Ziegler W et al. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension 1995;25:511-516.
47. [47] Pritchard KA, Jr., Schwarz SM, Medow MS, Stemerman MB. Effect of low-density lipoprotein on endothelial cell membrane fluidity and mononuclear cell attachment. Am J Physiol 1991;260:C43-C49.
48. [48] Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.
49. [49] Francis DA, Karras JG, Ke X, Sen R, Rothstein TL. Induction of the transcription factors NF-kappaB, AP-1, and NF-AT during B cell stimulation through the CD40 receptor, Int Immunol 1994;7:151-161.
50. [50] Liao JK. Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J Biol Chem 1994;269:12987-12992.
51. 12 subunit expression by oxidized low-density lipoprotein. J Clin Invest 1995;95:1457-1463.
52. [52] Tensen CP, Van Kesteren ER, Planta RJ et al. A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction. Proc Natl Acad Sci USA 1994;91:4816-4820.
53. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993;12:2005-2015.
54. [54] Xanthoudakis S, Miao GG, Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci USA 1994;91:23-27.
55. [55] Flescher E, Ledbetter JA, Schieven GL et al. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 1994;153:4880-4889.
56. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995;270:18 966-18 974.
57. [57] Ares MP, Kallin B, Eriksson P, Nilsson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells. Arterioscler Thromb Vase Biol 1995;15:1584-1590.
58. [58] Kawana M, Lee ME, Quertermous EE, Quertermous T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 1995;15:4225-4231.